Anti-inflammatory potential: Research suggests it may support the body's natural inflammatory response, which is critical for tissue healing and pain management
Instead of stacking multiple tissue-repair compounds, it pairs a single potent fat-loss compound with a single potent regenerative compound, creating a clean two-compound protocol that is easy to manage and well-supported by available research data
Wells T, Frame V, Soffer B, Shaw W, Zhang Z, Herrera P, Shahinfar S: Enal-april Pediatric Hypertension Collaborative study group: A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension
July 23-24, 2026 FDA meeting: The Pharmacy Compounding Advisory Committee will formally review BPC-157 (free base and acetate salt), KPV, TB-500, and MOTS-c at the FDA White Oak Campus